Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael N Pollak

Showing results (21-30 of 175) with videos related to

Pageof 18
Sort By:
Cancer Causes & Control : CCC|January 4, 2014
Type 2 diabetes and the risk of mortality among patients with prostate cancerLeah Bensimon, Hui Yin, Samy Suissa, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 16, 2005
Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer riskEva S Schernhammer, Jeff M Holly, Michael N Pollak, et al.
Cancer Causes & Control : CCC|March 15, 2008
Hormonal profile of diabetic men and the potential link to prostate cancerJocelyn S Kasper, Yan Liu, Michael N Pollak, et al.
Diabetes Care|August 28, 2012
The use of metformin and the incidence of lung cancer in patients with type 2 diabetesBrielan B Smiechowski, Laurent Azoulay, Hui Yin, et al.
The Biochemical Journal|July 15, 2014
Effects of metformin and other biguanides on oxidative phosphorylation in mitochondriaHannah R Bridges, Andrew J Y Jones, Michael N Pollak, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 12, 2002
Dietary correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrationsMichelle D Holmes, Michael N Pollak, Walter C Willett, et al.
American Journal of Epidemiology|August 26, 2003
Serum insulin-like growth factor I and subsequent risk of colorectal cancer among Japanese-American menAbraham M Y Nomura, Grant N Stemmermann, James Lee, et al.
Cancer Causes & Control : CCC|April 3, 2013
Androgen deprivation therapy and the risk of colorectal cancer in patients with prostate cancerJonathan Assayag, Hui Yin, Serge Benayoun, et al.
Neuroepidemiology|March 4, 2010
Fasting plasma insulin, C-peptide and cognitive change in older men without diabetes: results from the Physicians' Health Study IIOlivia I Okereke, Tobias Kurth, Michael N Pollak, et al.
Carcinogenesis|October 6, 2007
Silibinin suppresses in vivo growth of human prostate carcinoma PC-3 tumor xenograftRana P Singh, Gagan Deep, Marie-José Blouin, et al.
Pageof 18

Showing results (21-30 of 175) with videos related to

Sort By:
Pageof 18
Cancer Causes & Control : CCC|January 4, 2014
Type 2 diabetes and the risk of mortality among patients with prostate cancerLeah Bensimon, Hui Yin, Samy Suissa, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|March 16, 2005
Circulating levels of insulin-like growth factors, their binding proteins, and breast cancer riskEva S Schernhammer, Jeff M Holly, Michael N Pollak, et al.
Cancer Causes & Control : CCC|March 15, 2008
Hormonal profile of diabetic men and the potential link to prostate cancerJocelyn S Kasper, Yan Liu, Michael N Pollak, et al.
Diabetes Care|August 28, 2012
The use of metformin and the incidence of lung cancer in patients with type 2 diabetesBrielan B Smiechowski, Laurent Azoulay, Hui Yin, et al.
The Biochemical Journal|July 15, 2014
Effects of metformin and other biguanides on oxidative phosphorylation in mitochondriaHannah R Bridges, Andrew J Y Jones, Michael N Pollak, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 12, 2002
Dietary correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrationsMichelle D Holmes, Michael N Pollak, Walter C Willett, et al.
American Journal of Epidemiology|August 26, 2003
Serum insulin-like growth factor I and subsequent risk of colorectal cancer among Japanese-American menAbraham M Y Nomura, Grant N Stemmermann, James Lee, et al.
Cancer Causes & Control : CCC|April 3, 2013
Androgen deprivation therapy and the risk of colorectal cancer in patients with prostate cancerJonathan Assayag, Hui Yin, Serge Benayoun, et al.
Neuroepidemiology|March 4, 2010
Fasting plasma insulin, C-peptide and cognitive change in older men without diabetes: results from the Physicians' Health Study IIOlivia I Okereke, Tobias Kurth, Michael N Pollak, et al.
Carcinogenesis|October 6, 2007
Silibinin suppresses in vivo growth of human prostate carcinoma PC-3 tumor xenograftRana P Singh, Gagan Deep, Marie-José Blouin, et al.
Pageof 18